Suchergebnisse - "Powles, Thomas"

PubPharm (537)

1

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

enthalten in: The New England journal of medicine | 2024

von Choueiri, T. | Tomczak, P. | Park, S. | +131

2

Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens

enthalten in: The oncologist | 2024

von Saad, E. | Gebrael, G. | Semaan, K. | +17

3

Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations

enthalten in: JNCI cancer spectrum | 2024

von Necchi, A. | Ramlau, R. | Falcón González, A. | +19

4

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma : Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Motzer, R. | Porta, C. | Eto, M. | +134

5

Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM) : An Expert Opinion

enthalten in: Clinical genitourinary cancer | 2024

von Soares, A. | Bourlon, M. | Wong, A. | +14

6

CREST : phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer

enthalten in: Future oncology (London, England) | 2024

von Steinberg, G. | Shore, N. | Redorta, J. | +12

7

Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study

enthalten in: European urology | 2024

von Motzer, R. | Choueiri, T. | Hutson, T. | +15

8

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

enthalten in: Cancer cell | 2024

von Saliby, R. | Labaki, C. | Jammihal, T. | +21

9

NLR Outperforms Low Hemoglobin and High Platelet Count as Predictive and Prognostic Biomarker in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

enthalten in: Clinical genitourinary cancer | 2024

von Young, M. | Tapia, J. | Szabados, B. | +4

10

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer

enthalten in: The New England journal of medicine | 2024

von Powles, T. | Valderrama, B. | Gupta, S. | +122

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]